Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsResearchers showed that circulating tumor cells isolated from immunotherapy-resistant metastatic melanoma patients expressed higher levels of nuclear lysine specific demethylase 1 (LSD1) phosphorylated at serine 111 compared to responders, which is associated with co-expression of stem-like, mesenchymal genes.
[Frontiers in Immunology]
6445212 {6445212:343FBF8F} items 1 apa 0 default asc 1 150769 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-d6f2ec4779ffa51ac8a3acf75b82c025%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22343FBF8F%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tu%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%202em%3B%20text-indent%3A-2em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETu%2C%20W.%20J.%2C%20McCuaig%2C%20R.%20D.%2C%20Tan%2C%20A.%20H.%20Y.%2C%20Hardy%2C%20K.%2C%20Seddiki%2C%20N.%2C%20Ali%2C%20S.%2C%20%26%23x2026%3B%20Rao%2C%20S.%20%282020%29.%20Targeting%20Nuclear%20LSD1%20to%20Reprogram%20Cancer%20Cells%20and%20Reinvigorate%20Exhausted%20T%20Cells%20via%20a%20Novel%20LSD1-EOMES%20Switch.%20%3Ci%3EFrontiers%20in%20Immunology%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.01228%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.01228%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D343FBF8F%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20Nuclear%20LSD1%20to%20Reprogram%20Cancer%20Cells%20and%20Reinvigorate%20Exhausted%20T%20Cells%20via%20a%20Novel%20LSD1-EOMES%20Switch%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%20Juan%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22McCuaig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abel%20H.%20Y.%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristine%22%2C%22lastName%22%3A%22Hardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabila%22%2C%22lastName%22%3A%22Seddiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayed%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jane%20E.%22%2C%22lastName%22%3A%22Dahlstrom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%20G.%22%2C%22lastName%22%3A%22Bean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenny%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jade%22%2C%22lastName%22%3A%22Forwood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sofia%22%2C%22lastName%22%3A%22Tsimbalyuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Desmond%22%2C%22lastName%22%3A%22Yip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laeeq%22%2C%22lastName%22%3A%22Malik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thiru%22%2C%22lastName%22%3A%22Prasanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Milburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudha%22%2C%22lastName%22%3A%22Rao%22%7D%5D%2C%22abstractNote%22%3A%22Lysine%20specific%20demethylase%201%20%28LSD1%29%20is%20a%20key%20epigenetic%20eraser%20enzyme%20implicated%20in%20cancer%20metastases%20and%20recurrence.%20Nuclear%20LSD1%20phosphorylated%20at%20serine%20111%20%28nLSD1p%29%20has%20been%20shown%20to%20be%20critical%20for%20the%20development%20of%20breast%20cancer%20stem%20cells.%20Here%20we%20show%20that%20circulating%20tumor%20cells%20isolated%20from%20immunotherapy-resistant%20metastatic%20melanoma%20patients%20express%20higher%20levels%20of%20nLSD1p%20compared%20to%20responders%2C%20which%20is%20associated%20with%20co-expression%20of%20stem-like%2C%20mesenchymal%20genes.%20Targeting%20nLSD1p%20with%20selective%20nLSD1%20inhibitors%20better%20inhibits%20the%20stem-like%20mesenchymal%20signature%20than%20traditional%20FAD-specific%20LSD1%20catalytic%20inhibitors%20such%20as%20GSK2879552.%20We%20also%20demonstrate%20that%20nLSD1p%20is%20enriched%20in%20PD-1%2BTIM3%2BCD8%2B%20T%20cells%20from%20resistant%20melanoma%20patients%20and%204T1%20immunotherapy-resistant%20mice.%20Targeting%20the%20LSD1p%20nuclear%20axis%20induces%20IFN%5Cuf067%5C%2FTNF%5Cu03b1-expressing%20CD8%2B%20T%20cell%20infiltration%20into%20the%20tumors%20of%204T1%20immunotherapy-resistant%20mice%2C%20which%20is%20further%20augmented%20by%20combined%20immunotherapy.%20Underpinning%20these%20observations%2C%20nLSD1p%20is%20regulated%20by%20the%20key%20T%20cell%20exhaustion%20transcription%20factor%20EOMES%20in%20dysfunctional%20CD8%2B%20T%20cells.%20EOMES%20co-exists%20with%20nLSD1p%20in%20PD-1%2BCD8%2B%20T%20cells%20in%20resistant%20patients%2C%20and%20nLSD1p%20regulates%20EOMES%20nuclear%20dynamics%20via%20demethylation%5C%2Facetylation%20switching%20of%20critical%20EOMES%20residues.%20Using%20novel%20antibodies%20to%20target%20these%20post-translational%20modifications%2C%20we%20show%20that%20EOMES%20demethylation%5C%2Facetylation%20is%20reciprocally%20expressed%20in%20resistant%20and%20responder%20patients.%20Overall%2C%20we%20show%20for%20the%20first%20time%20that%20dual%20inhibition%20of%20metastatic%20cancer%20cells%20and%20re-invigoration%20of%20the%20immune%20system%20requires%20LSD1%20inhibitors%20that%20target%20the%20nLSD1p%20axis.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.01228%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffimmu.2020.01228%5C%2Ffull%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-16T17%3A08%3A27Z%22%7D%7D%5D%7D
Tu, W. J., McCuaig, R. D., Tan, A. H. Y., Hardy, K., Seddiki, N., Ali, S., … Rao, S. (2020). Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01228 Cite
